AVATAR MEDICAL, the Medical Image VR platform that facilitates the preparation of complex surgeries, today announced it has been named a winner in the Start-up Slams 2020 organized by MedFIT.
AVATAR MEDICAL, a ground-breaking spin-off from the Institut Pasteur and Institut Curie, leverages virtual reality and standard medical images (e.g. CT-scan, MRI) to instantly create realistic to-scale patient avatars for surgeons to use in pre-operative planning. Developed hand-in-hand with leading surgery departments, AVATAR MEDICAL radically changes how surgeons access, interpret, and act upon the valuable clinical information contained in medical images. Benefitting from three years of advanced computer vision & Bayesian inference research, AVATAR MEDICAL was incorporated in Paris in July 2020 by an experienced team of French and American founders, and also operates in the USA.
The company currently focuses on improving the preparation of breast cancer surgeries and will explore further applications in oncology in 2021 in several pilot sites. The full commercial deployment of the regulatory approved (FDA and CE) version of the software platform is expected in 2022.
“It’s a great honor to be recognized as the most innovative start-up among a number of valuable candidates,” said Elodie Brient-Litzler, COO and Co-founder, who presented AVATAR MEDICAL’s Medical Imaging VR Platform to an esteemed jury panel.
Awarding AVATAR MEDICAL at the prestigious industry ceremony, the judges said that AVATAR MEDICAL “has an impressive approach” and is a “very compelling solution”.
The Start-up Slams- a 4-day event, which was contested by young companies from around 8 different countries in a virtual format this year, celebrates the best of innovation in the MedTech, Diagnostic, and Digital Health sectors.
After being judged and challenged to the most rigorous standards by various committee members, an independent panel of industry experts advises and provides feedback to early-stage companies who present their global strategy and innovation.